Active	Status	Sponsor type	Region	Phase	Filter
4 Active 1 Inactive 5 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Zepeda, David
NCT05511948: Randomized and Open Label Study for Safety and Efficacy of DBI-102 vs. Vehicle vs. Hydroquinone on Skin Pigmentation and Lentigos	Completed	2	75	RoW	DBI-102, Vehicle gel, Hydroquinone Cream	DermBiont, Inc.	Hyperpigmentation	03/23	03/23
NCT05136144: Adaptive Design Study for Safety and Efficacy of Treatment Regimens With SM-020 in Subjects With Seborrheic Keratosis	Active, not recruiting	2	70	RoW	SM-020	DermBiont, Inc., Zepeda Dermatologia	Seborrheic Keratosis	05/24	07/24
NCT06454747: Randomized Study Using SM-030 Gel for Adults With Melasma	Recruiting	2	138	RoW	SM-030 gel 0.64%, Placebo gel, SM-030 gel 0.08%	DermBiont, Inc., Fortrea	Melasma	04/25	10/25
Zepeda, Daivd
NCT06454747: Randomized Study Using SM-030 Gel for Adults With Melasma	Recruiting	2	138	RoW	SM-030 gel 0.64%, Placebo gel, SM-030 gel 0.08%	DermBiont, Inc., Fortrea	Melasma	04/25	10/25